Home | FAQs | About Us | Partner With Us | In the News | Related Links | Contact Us | Campaign Materials

---

Email Updates

Print Page

Email Page

Send an E-Card

Link to Us

Widgets

6/6/2008

New genetic research helps explain why some smokers respond better to certain smoking-cessation programs than others. Researchers at Duke University and the National Institute on Drug Abuse describe for the first time a set of genes, about 100 in all, that seem to predict how well a smoker will respond to two different types of quitting programs — nicotine replacement or bupropion (Zyban).